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Combined associations of body weight and lifestyle factors 
with all cause and cause specific mortality in men and women: 
prospective cohort study
Nicola Veronese,1,2 Yanping Li,3 JoAnn E Manson,4,5,6 Walter C Willett,3,4,5 Luigi Fontana,1,7,8 Frank B Hu3,4,5 
ABSTRACT
ObjeCtive
To evaluate the combined associations of diet, 
physical activity, moderate alcohol consumption, 
and smoking with body weight on risk of all cause and 
cause specific mortality.
Design
Longitudinal study with up to 32 years of follow-up.
setting
Nurses’ Health Study (1980-2012) and Health 
Professionals Follow-up Study (1986-2012).
PartiCiPants
74 582 women from the Nurses’ Health Study and 
39 284 men from the Health Professionals Follow-up 
Study who were free from cardiovascular disease and 
cancer at baseline.
Main OutCOMe Measures
Exposures included body mass index (BMI), score on 
the alternate healthy eating index, level of physical 
activity, smoking habits, and alcohol drinking while 
outcome was mortality (all cause, cardiovascular, 
cancer). Cox proportional hazard models were used to 
calculate the adjusted hazard ratios of all cause, 
cancer, and cardiovascular mortality with their 95% 
confidence intervals across categories of BMI, with 
22.5-24.9 as the reference.
results
During up to 32 years of follow-up, there were 30 013 
deaths (including 10 808 from cancer and 7189 from 
cardiovascular disease). In each of the four categories 
of BMI studied (18.5-22.4, 22.5-24.9, 25-29.9, 
≥30), people with one or more healthy lifestyle factors 
had a significantly lower risk of total, cardiovascular, 
and cancer mortality than individuals with no low risk 
lifestyle factors. A combination of at least three low 
risk lifestyle factors and BMI between 18.5-22.4 was 
associated with the lowest risk of all cause (hazard 
ratio 0.39, 95% confidence interval 0.35 to 0.43), 
cancer (0.40, 0.34 to 0.47), and cardiovascular (0.37, 
0.29 to 0.46) mortality, compared with those with BMI 
between 22.5-24.9 and none of the four low risk 
lifestyle factors.
COnClusiOn
Although people with a higher BMI can have lower risk 
of premature mortality if they also have at least one 
low risk lifestyle factor, the lowest risk of premature 
mortality is in people in the 18.5-22.4 BMI range with 
high score on the alternate healthy eating index, high 
level of physical activity, moderate alcohol drinking, 
and who do not smoke. It is important to consider diet 
and lifestyle factors in the evaluation of the 
association between BMI and mortality.
Introduction
Data from experimental, epidemiological, and clinical 
studies indicate that leanness is associated with greater 
metabolic health and a lower risk of developing type 2 
diabetes, cardiovascular disease, and cancer.1-3  Data 
from some epidemiological studies, however, are chal-
lenging this concept and suggest that being overweight, 
and possibly even mildly obese, is associated with a 
reduced risk of mortality.4 5  Normal weight, defined as a 
body mass index (BMI) between 18.5-24.9, is a broad ref-
erence group containing not only non-smokers who are 
lean because they are physically active and eating 
healthy diets but also those who are within the normal 
BMI range for other reasons that accelerate the ageing 
process (such as chronic inflammation, chronic 
obstructive pulmonary disease, and neurodegenerative 
diseases), probably leading to an artificially reduced 
mortality among the overweight and moderately obese 
groups.6-10  Therefore, when evaluating the relation 
between BMI and mortality, it might be important to 
consider lifestyle factors such as smoking, diet, moder-
ate alcohol intake, and physical activity levels. In addi-
tion, the epidemiological studies that reported that 
overweight and obesity could be associated with 
reduced mortality have some important limitations. For 
example, they did not consider diet and lifestyle fac-
tors, did not exclude participants with exiting chronic 
diseases, and had a short duration of follow-up.6
Given this background, in this large prospective 
cohort study, we examined the joint associations of BMI 
and lifestyle factors with all cause, cardiovascular, and 
cancer mortality among 74 582 women from the Nurses’ 
Health Study (NHS, 1980-2012) and 39 284 men from the 
Health Professionals Follow-up Study (HPFS, 1986-
2012) who were free from cardiovascular disease and 
WhAT IS AlReAdy knoWn on ThIS TopIC
Leanness is associated with greater metabolic health and a lower risk of type 2 
diabetes, cardiovascular disease, cancer, and all cause mortality
Data from some epidemiological studies suggest that being overweight, and 
possibly even mildly obese, is associated with a reduced risk of mortality
WhAT ThIS STudy AddS
The U shaped relation between BMI and mortality observed in many 
epidemiological studies is driven by an over-representation of individuals who are 
lean because of chronic metabolic and pathological conditions caused by exposure 
to smoking, a sedentary lifestyle, and/or unhealthy diets, making them more 
susceptible to death
Among overweight and obese individuals, those with one or more low risk lifestyle 
behaviors have a significantly lower risk of premature mortality 
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cancer at baseline and followed up for over 32 years. We 
hypothesized that individuals who were lean had the 
lowest risk of mortality, particularly if normal weight 
was associated with regular exercise, a healthy diet, 
and no smoking.
Methods
study population
The Health Professionals Follow-up Study (HPFS) was 
established in 1986, when 51 529 male US health profes-
sionals (dentists, optometrists, osteopaths, podiatrists, 
pharmacists, and veterinarians) aged 40-75 completed 
a mailed questionnaire about their medical history and 
lifestyle.11  The Nurses’ Health Study (NHS) began in 
1976, when 121 701 female nurses aged 30-55 responded 
to a questionnaire regarding medical, lifestyle, and 
other health related information.11 Both cohorts were 
designed with similar questions on diet, exercise, 
smoking status, and other factors (the use of hormone 
replacement therapies and questions related to repro-
duction were asked only in the nurses’ study). In both 
cohorts, questionnaires have been sent every two years 
to update this information and identify participants 
with various newly diagnosed diseases. We excluded 
participants with previous diagnoses of cancer and car-
diovascular diseases at baseline (see table A in 
 appendix 1). We also excluded participants with miss-
ing values at baseline for BMI, level of physical activity, 
score on a food frequency questionnaire, or smoking. 
After these exclusions, we included 74 582 women and 
39 284 men.
Patient involvement
No patients were involved in setting the research ques-
tion or the outcome measures, nor were they involved in 
the design and implementation of the study. There are 
no plans to involve patients in dissemination.
assessment of exposure
Diet was assessed with a validated food frequency ques-
tionnaire that asked how often, on average, a partici-
pant had consumed a particular amount of a specific 
type of food during the previous year.12  The intake of 
nutrients was computed by multiplying the frequency 
of consumption of each unit of food by its nutrient con-
tent, and consumption of alcoholic drinks was also con-
sidered. Diet quality was assessed with the score on the 
alternate healthy eating index (AHEI), which is strongly 
associated with the onset of metabolic and cardiovas-
cular diseases in the general population.13 14  Briefly, we 
assigned points for intake of each component on a scale 
from 0 to 10, with 10 indicating adherence to the recom-
mended levels of servings per day and 0 the worst 
intake. Use of multivitamins was scored as 2.5 points for 
up to four years of use and 7.5 points for five or more 
years of use. We included 10 components of the index in 
our diet score: higher intakes of vegetables, fruit, nuts, 
whole grains, polyunsaturated fatty acids, and long 
chain omega 3 fatty acids and lower intakes of red and 
processed meats, sugar sweetened beverages, trans 
fats, and sodium. In this analysis, scores were divided 
into fifths, with the two upper fifths classified as health-
ier diets.15-17 The information about diet was updated 
every four years.
We investigated levels of physical activity using a val-
idated questionnaire, which was updated every two 
years.18  We estimated the hours participants spent each 
week doing moderate-to-vigorous activities (including 
brisk walking) that required at least the expenditure of 
at least 3 MET (metabolic equivalent units) per hour. 
The validity and reproducibility of the questionnaire 
have been evaluated and reported previously. Briefly, 
the correlation between physical activity as reported in 
one week recalls and that reported on the question-
naires was 0.79. The correlation between moderate to 
vigorous activity reported in diaries and that reported 
on the questionnaires was 0.62.19
Smoking habits were categorized as never smoked, 
former smoker, or current smoker (including the num-
ber of cigarettes smoked a day) and updated every two 
years. Body mass index was calculated as self reported 
weight (kg)/height (m)2. In our validation study, the cor-
relation between self reported and technician measured 
weight was 0.97.20
Definition of low risk lifestyle group
Low risk lifestyle factors included never smoking, phys-
ical activity levels ≥30 min/day at moderate to vigorous 
intensity, moderate alcohol consumption defined as 
5-15 g alcohol/day in women and 5-30 g alcohol/day in 
men,21 and the AHEI score in the upper two fifths. Each 
factor was coded as 0 or 1, and the sum of these four 
scores together gave a final score of 0, 1, 2, 3, or 4, with 
higher scores indicating a healthier lifestyle.
assessment of other confounders
Information on potential confounders—such as age, 
ethnicity, use of multivitamins, regular use of aspirin, 
postmenopausal use of hormones (nurses’ study only), 
and family history of diabetes, cancer, or myocardial 
infarction (in first degree relatives)—was collected with 
biennial questionnaires.
ascertainment of deaths
We identified deaths from state vital statistics records, 
the national death index, reports by the families, and 
the postal system.22 The follow-up for death in both 
cohorts was at least 98% complete. Cause of death was 
identified from death certificates or review of medical 
records. In the current analysis, we evaluated all cause 
mortality and death from cardiovascular disease (inter-
national classification of diseases, eighth revision 
(ICD-8) codes 390-458) or cancer (ICD-8 codes 140-207).
statistical analysis
Participants contributed person time from the return of 
the baseline questionnaire (1980 for NHS; 1986 for 
HPFS) until the date of death, loss to follow-up, or the 
end of the follow-up period (30 June 2012 and 30 Janu-
ary 2012, respectively), whichever came first.
We evaluated the proportional hazards assumption 
with a likelihood ratio test comparing the model with 
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and without an interaction term between time period 
and the joint categories of BMI and lifestyles. The P 
value for the proportional hazards assumption was 
0.44, indicating that the assumption was not violated in 
our analyses. We therefore used Cox proportional haz-
ard models to calculate adjusted hazard ratios for all 
cause, cancer, and cardiovascular mortality with their 
95% confidence intervals across the categories of BMI 
(<18.5, 18.5-22.4, 22.5-24.9, 25.0-27.4, 27.5-29.9, 30.0-34.9, 
35.0-39.9, and ≥40).23  We defined the BMI range of 22.5-
24.9 as the reference category, as in previous studies.24 
In our cohorts this was also the range of BMI associated 
with the lowest mortality (fig A in appendix 2).
We updated the information during follow-up using 
the most recently available information on BMI and life-
style factors in which risks of mortality were predicted 
from the information derived from the most recent 
questionnaire. For example, in the nurses’ study, 
deaths that occurred from 1 July 1980 to 30 June 1982 
were examined in relation to BMI and lifestyle factors 
based on data collected in the 1980 questionnaire; 
deaths occurring from 1 July 1982 to 30 June 1984 were 
examined in relation to BMI and lifestyle factors based 
on data collected in the 1982 questionnaire, and so 
forth. For AHEI score, it was updated every four years. 
The same analytic strategy was applied to HPFS. To 
minimize potential reverse causality bias, we stopped 
updating body weight once a participant had a diagno-
sis of chronic diseases such as cancer, cardiovascular 
diseases, or diabetes. The covariates included in the 
multivariable model were age, ethnicity, current use of 
multivitamins, current use of aspirin, status with regard 
to a family history of diabetes mellitus, myocardial 
infarction, or cancer; and, for women, menopausal sta-
tus and hormone use. If data were missing at a given 
time point, we carried forward the last observation for 
one cycle.
We applied two approaches to deal with confounding 
by smoking: one was based on the whole study popula-
tion by adjusting for smoking status among people with 
different BMI categories to minimize the confounding 
effects of smoking; the other was to analyze only partic-
ipants who had never smoked.
We calculated the hazard ratios across joint classifi-
cation of number of low risk lifestyle factors (0, 1, 2, or 
≥3) and BMI (18.5-22.4, 22.5-24.9, 25.29.9, and ≥30) 
because there were too few cases for cause specific mor-
tality in some groups (see table B in appendix 1). A sim-
ilar analysis was performed considering only the effect 
of AHEI, moderate alcohol consumption, and physical 
activity levels for each BMI category after we excluded 
participants who had ever smoked.
We ran several sensitivity analyses to test the robust-
ness of our results. First, we kept all missing values at 
baseline and during follow-up and imputed missing 
values of BMI and lifestyle factors by applying a multi-
ple imputation approach. Second, we calculated an 
expanded low risk lifestyle score by assigning weights 
to each low risk factor based on the β coefficients from 
the multivariable adjusted Cox model with all cause 
mortality as the outcome. We then summed the prod-
ucts of each binary lifestyle score multiplied by its 
weight, divided it by the sum of all β coefficient values, 
and then multiplied by 4 to make the low risk lifestyle 
score easier to interpret. In this way, the expanded low 
risk lifestyle score ranged from 0 to 4, and each unit of 
low risk lifestyle score represented the change in one 
risk factor. Third, we conducted analyses that assessed 
the effects of specific combination of lifestyle factors on 
mortality. We used SAS version 9.3 to analyze the data. 
Significance was set at a two tailed P<0.05.
Results
At baseline, we included 74 582 women from the NHS 
and 39 284 men from the HPFS. Table 1 shows the char-
acteristics of the study population for men and women. 
Table C in appendix 1 shows their characteristics 
according to baseline BMI categories. As reported in 
table D in appendix 1, 8.9% of women and 19.6% of men 
had three or more low risk factors.
During up to 32 years of follow-up, 30 013 partici-
pants died (10 808 from cancer and 7189 from cardio-
vascular disease). There was a U shaped relation 
between BMI and mortality among the whole study 
population (table 2 ), which was consistent in both 
women and men. Compared with those with BMI in the 
22.5-24.9 range, those in most other BMI categories had 
an increased risk of all cause mortality after adjustment 
for potential confounders (table 2 ). After we excluded 
people who ever smoked, we found a linear relation 
between BMI and risk of mortality with the nadir in the 
18.5-22.4 BMI range (table 2).
There was a significant interaction between BMI and 
numbers of low risk lifestyle factors (P<0.001 for interac-
tion, table 3 ). Among participants without any low risk 
lifestyle factor, the association between BMI and mortal-
ity was U shaped (P<0.001 for non-linear trend, P=0.81 
for linear trend). Compared with participants with BMI 
of 22.5-24.9, those with either BMI <22.5 or >27.5 had a 
significantly higher hazard ratio for mortality (table 3). 
Among participants with one or more low risk lifestyle 
factors the association between BMI and mortality was 
more linear (P<0.001 for linear trend). Among people 
with three or four low risk lifestyle factors, compared 
with those with BMI 22.5-24.9, only participants with BMI 
>27.5, but not those with BMI <22.5, had a significantly 
higher hazard ratio for mortality (table 3).
table 1 | age adjusted baseline characteristics of participants in nurses’ Health study 
(nHs, 1980) and Health Professions’ Follow-up study (HPFs, 1986)
nHs, 1980 HPFs, 1986
No of participants 74 582 39 284
Mean (SD) age (years) 45.9 (7.2) 52.9 (9.5)
Mean (SD) BMI 24.3 (4.5) 25.5 (3.3)
Mean (SD) score on AHEI 31.0 (6.2) 46.7 (10.8)
Mean (SD) physical activity (hours/week) 3.9 (2.9) 2.8 (4.2)
Mean (SD) alcohol consumption (g/day) 6.4 (10.6) 11.4 (15.4)
Current smoking (%) 28.8 9.8
High blood pressure (%) 15.5 19.7
Hypercholesterolemia (%) 5.1 10.5
Diabetes (%) 2.1 2.4
BMI=body mass index; AHEI=alternate healthy eating index.
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The risk of mortality significantly decreased with the 
increasing number of low risk lifestyle factors. A combi-
nation of at least three low risk lifestyle factors and BMI 
between 18.5-22.4 was associated with the lowest risk of 
total (hazard ratio 0.39, 95% confidence interval 0.35 to 
0.43), cancer (0.40, 0.34 to 0.47), and cardiovascular 
(0.37, 0.29 to 0.46) mortality, compared with those with 
BMI between 22.5-24.9 and none of the four low risk life-
style factors (fig 1 ). These findings were confirmed in 
those who had never smoked (0.45, 0.33 to 0.61, for all 
cause mortality; 0.47, 0.29 to 0.77, for cancer mortality; 
0.41, 0.21 to 0.80, for cardiovascular disease mortality) 
(fig 2).
In each of the four BMI categories (18.5-22.4, 22.5-24.9, 
25-29.9, ≥30), with participants without any low risk fac-
tors as the reference, those with one, two, three, or four 
low risk factors had a graded lower risk for all cause and 
cause specific mortality (all P<0.001 for trend, fig 1).
The results of sensitivity analyses with multiple impu-
tations (fig B in appendix 2), expanded low risk lifestyle 
scores (fig C in appendix 2), or specific combinations of 
lifestyle factors in the low risk category (fig D in appen-
dix 2) were similar to those from the main analysis.
discussion
After adjustment for the effect of high levels of physical 
activity, healthy diet (AHEI scores), moderate alcohol 
drinking, and never smoking, men and women with a 
BMI in the range 18.5-22.4 have a significantly lower risk 
of cardiovascular disease, cancer, and total mortality. 
In contrast, men and women with a BMI <22.4 and 
unhealthy lifestyles had a significantly higher risk of 
mortality than overweight individuals. Our findings 
suggest that the U shaped relation between BMI and 
mortality detected in previous epidemiological studies 
could result from an over-representation of people in 
our industrialized societies who are, or most likely 
became, lean because of the chronic accumulation of 
metabolic, inflammatory, and pathological conditions 
caused by long term exposure to smoking, a sedentary 
lifestyle, and unhealthy diets. Interestingly, our data 
indicate that even in overweight and obese individuals, 
the exposure to one or more low risk lifestyle behaviors 
significantly reduced their risk of mortality.
results in relation to other studies
Many epidemiological studies have shown a U shaped 
relation between BMI and mortality, with some studies 
showing the lowest mortality associated with BMI 
around 22.5-25 and others around 25-29.9.4 25  Our data 
confirm the U shape relation, with an increased risk 
associated with BMI <22.4 and ≥30, as recently reported 
in a large meta-analysis of 189 studies without smokers 
and almost four million participants.26  Our data, how-
ever, showed for the first time that among men and 
women who have never smoked with healthier diets, 
moderate alcohol intake, and regular exercise for 
≥30 min/day at moderate intensity, there was a linear 
relation between BMI and risk of mortality with the 
nadir in the 18.5-22.4 BMI category. The problem is that 
few people in North America and Europe are both t
ab
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 normal weight and practice a healthy lifestyle (that is, 
not smoking, exercising regularly, moderate alcohol 
consumption, and eating a healthy diet).27  In this study 
of US health professionals, only 19.6% of men and 8.9% 
of women had three or more low risk lifestyle factors. 
Our findings suggest that in a substantial proportion of 
the US population, leanness is driven by other factors 
that can increase risk of mortality, including existing or 
preclinical chronic diseases that can cause weight loss 
and cigarette smoking, which is also associated with 
lower body weight. The reverse causation problem (that 
is, low BMI as a consequence of chronic diseases) might 
be particularly pronounced among those who were sed-
entary and consuming unhealthy diets, conditions that 
are important determinants of chronic disease morbid-
ity and mortality. This could explain why we observed 
an increased mortality in the low BMI range of 18.5-22.4 
only among those who did not follow a healthy lifestyle, 
but not among those with a relatively healthy lifestyle. 
Increasingly research suggests that smoking, a seden-
tary lifestyle, and unhealthy hypercaloric diets cause an 
overstimulation of multiple mitogenic, inflammatory, 
and oxidative pathways.28-30  These factors can acceler-
ate the accumulation of unrepaired molecular damage 
and senescent cells, stimulate the DNA damage 
response, inhibit stem cell regenerative function, and 
promote involuntary weight loss, organ dysfunction, 
and frailty.7 10 31-33
Our findings agree with those of a recent meta-analy-
sis, including about 30 million participants, that 
showed that overweight and obesity are associated with 
increased risk of all cause mortality, with the nadir of 
the curve observed at BMI 23-24 among those who had 
never smoked, 22-23 among healthy people who had 
never smoked, and 20-22 in studies with a follow-up 
over 20 years.34  In our study, the nadir of the curve was 
observed at BMI 18.5-22.4 among people who had never 
smoked and a follow-up period up to 32 years. Of note, 
in a recent study conducted among three Danish 
cohorts, the BMI associated with the lowest all cause 
mortality increased by 3.3 units from cohorts enrolled 
from 1976-78 to 2003-13.35 The average duration of fol-
low-up for the 2003-13 cohort, however, was only 4.6 
years, and thus the shift to higher BMI associated with 
the lowest mortality in this cohort is possibly because of 
reverse causation bias (that is, individuals with pre- 
existing or preclinical diseases have increased mortal-
ity but lower BMI because of weight loss). It should be 
noted that these studies, unlike ours, did not take into 
account diet and lifestyle factors.
Potential mechanisms
BMI is a crude but practical and inexpensive tool to 
measure adiposity in large population studies.23 36  It 
does not, however, measure the ratio of lean to fat or the 
distribution of fat and, most importantly, the relative 
contribution of lifestyle and other metabolic factors on 
the risk of developing a chronic disease and dying pre-
maturely. In this study, we showed that in each of the 
four categories of BMI (18.5-22.4, 22.5-24.9, 25-29.9, 
≥30), men and women with healthy lifestyles had sig-
nificantly lower cardiovascular disease, cancer, and 
total mortality. Interestingly, even within the obese cat-
egory, individuals who did not smoke, ate healthier 
diets, drank a moderate quantity of alcohol, and exer-
cised regularly had a much lower risk of mortality than 
those who had none of above low risk lifestyle factors. 
The mechanisms responsible for the protective effects 
of healthy lifestyles in these individuals are not com-
pletely known but probably encompass a series of met-
abolic and molecular alterations induced by exercise 
training, healthier diets rich in vitamins and phyto-
chemicals, and avoidance of smoking. These conditions 
probably inhibit insulin resistance, inflammation, and 
oxidative stress and slow the accumulation of cellular 
and organ damage.3 30-32 Our results show that the 
health benefit of engaging in even one healthy lifestyle 
behavior is seen in all BMI categories, especially among 
those in the unhealthy BMI categories.
strengths and limitations
Our analysis was based on a large sample size and a 
long follow-up with a large number of deaths, which 
provide high statistical power. Another important 
strength is the high follow-up rate. In each two or four 
year cycle of the survey of our cohorts, follow-up rates 
have averaged 94%. In addition, our study includes the 
repeated measurements of diet, physical activity, smok-
ing, and other factors. Furthermore, we examined not 
No low risk factor
  18.5-22.4
  22.5-24.9
  25.0-29.9
  ≥30
One low risk factor
  18.5-22.4
  22.5-24.9
  25.0-29.9
  ≥30
Two low risk factors
  18.5-22.4
  22.5-24.9
  25.0-29.9
  ≥30
Three low risk factors
  18.5-22.4
  22.5-24.9
  25.0-29.9
  ≥30
210.2 210.2
Hazard ratio
(95% CI)
All cause mortality
Hazard ratio
(95% CI)
Cancer mortality
Hazard ratio
(95% CI)
Cardiovascular mortality
Fig 1 | Hazard ratios for all cause and cause specific mortality according to joint 
classification of low risk lifestyle score and bMi based on pooled results from nHs and 
HPFs cohorts. adjusted for age; race; current use of multivitamins and aspirin; status with 
regard to family history of diabetes mellitus, myocardial infarction, or cancer; and, for 
women, menopausal status and hormone use. low risk lifestyles include never smoking, 
exercise ≥30 min/day at moderate or vigorous intensity, aHei score in upper two fifths, 
and moderate alcohol consumption (5-15 g alcohol/day in women, 5-30 g alcohol/day in 
men). each factor coded as 0 or 1 and four scores summed, so healthy lifestyles scores 
were 0, 1, 2, 3, or 4 (healthiest)
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only the relation between BMI, major lifestyle factors, 
and all cause mortality but also cause specific mortality.
There are, however, some potential limitations. Our 
cohorts included only health professionals, mostly 
white men and women, which might limit the 
 generalizability of the findings. The relative homogene-
ity of the study population in educational attainment 
and socioeconomic status, however, enhances the 
internal validity. Also, though measurement errors in 
self reported lifestyle factors are inevitable, because of 
the prospective design these errors are typically unre-
lated to the outcomes of the study and are thus likely to 
have attenuated the observed associations.
Conclusions and policy implications
In conclusion, people in the 18.5-22.4 BMI range with 
high levels of physical activity, healthy diets, and mod-
erate alcohol consumption and who do not smoke have 
a substantially lower rate of prematuremortality. One or 
more low risk lifestyle behaviors also significantly 
reduce the risk of mortality in overweight and obese 
individuals. Our data suggest that the U shaped relation 
between BMI and mortality observed in many epidemi-
ological studies is driven by an over-representation in 
our societies of individuals who are lean because of 
chronic metabolic and pathological conditions caused 
by exposure to smoking, a sedentary lifestyle, and/or 
unhealthy diets. Finally, our findings indicate that 
 leanness induced by healthy lifestyles is the optimal 
way to promote healthy longevity and to reduce the risk 
of premature death.
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